Skip to navigation bar Skip to breadcrumbs Skip to page content
clear place holder
Envelope icon E-mail Updates Teal square Text size:  a A A

cobweb icon Archived: Breast and Ovarian Cancer: BRCA Genetic Testing, September 2005

Original Release Date: September 2005

This version of this topic is currently archived and inactive. It should be used for historical purposes only.

Archived: Recommendation Summary

Summary of Recommendations

PopulationRecommendationGrade
(What's This?)
Women, Not at Increased Risk

The U.S. Preventive Services Task Force (USPSTF) recommends against routine referral for genetic counseling or routine breast cancer susceptibility gene (BRCA) testing for women whose family history is not associated with an increased risk for deleterious mutations in breast cancer susceptibility gene 1 (BRCA1) or breast cancer susceptibility gene 2 (BRCA2).

D
Women, at Increased Risk

The USPSTF recommends that women whose family history is associated with an increased risk for deleterious mutations in BRCA1 or BRCA2 genes be referred for genetic counseling and evaluation for BRCA testing.

B

Archived: Related Information for Consumers

Archived: Related Information for Health Professionals

Archived: Clinical Summary

Clinical summaries are one-page documents that provide guidance to primary care clinicians for using recommendations in practice.

There is no Clinical Summary for this recommendation.

 
Current as of: July 2015

Internet Citation: Final Update Summary: Breast and Ovarian Cancer: BRCA Genetic Testing, September 2005 . U.S. Preventive Services Task Force. July 2015.
https://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/breast-cancer--brca-testing-ovarian-cancer-screeni

USPSTF Program Office   5600 Fishers Lane, Mail Stop 06E53A, Rockville, MD 20857